IRIS Accounts Production v25.2.0.378 08398099 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh083980992024-03-31083980992025-03-31083980992024-04-012025-03-31083980992023-03-31083980992023-04-012024-03-31083980992024-03-3108398099ns15:EnglandWales2024-04-012025-03-3108398099ns14:PoundSterling2024-04-012025-03-3108398099ns10:Director12024-04-012025-03-3108398099ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3108398099ns10:SmallEntities2024-04-012025-03-3108398099ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3108398099ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3108398099ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3108398099ns10:FullAccounts2024-04-012025-03-3108398099ns10:OrdinaryShareClass12024-04-012025-03-3108398099ns10:OrdinaryShareClass22024-04-012025-03-3108398099ns10:OrdinaryShareClass32024-04-012025-03-3108398099ns10:Director22024-04-012025-03-3108398099ns10:Director32024-04-012025-03-3108398099ns10:Director42024-04-012025-03-3108398099ns10:RegisteredOffice2024-04-012025-03-3108398099ns5:CurrentFinancialInstruments2025-03-3108398099ns5:CurrentFinancialInstruments2024-03-3108398099ns5:Non-currentFinancialInstruments2025-03-3108398099ns5:Non-currentFinancialInstruments2024-03-3108398099ns5:ShareCapital2025-03-3108398099ns5:ShareCapital2024-03-3108398099ns5:CapitalRedemptionReserve2025-03-3108398099ns5:CapitalRedemptionReserve2024-03-3108398099ns5:RetainedEarningsAccumulatedLosses2025-03-3108398099ns5:RetainedEarningsAccumulatedLosses2024-03-3108398099ns5:LandBuildings2024-04-012025-03-3108398099ns5:PlantMachinery2024-04-012025-03-3108398099ns5:LandBuildings2024-03-3108398099ns5:PlantMachinery2024-03-3108398099ns5:LandBuildings2025-03-3108398099ns5:PlantMachinery2025-03-3108398099ns5:LandBuildings2024-03-3108398099ns5:PlantMachinery2024-03-3108398099ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108398099ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108398099ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2025-03-3108398099ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-03-3108398099ns5:Non-currentFinancialInstruments2024-04-012025-03-3108398099ns10:OrdinaryShareClass12025-03-3108398099ns10:OrdinaryShareClass22025-03-3108398099ns10:OrdinaryShareClass32025-03-31
REGISTERED NUMBER: 08398099 (England and Wales)















GOLDEN GROVE NURSERY LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025






GOLDEN GROVE NURSERY LIMITED (REGISTERED NUMBER: 08398099)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3 to 5


GOLDEN GROVE NURSERY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: E R Ward
Mrs J Ward
T M Ward
Mrs K Ward





REGISTERED OFFICE: The Conifers
Golden Grove
Wigtoft
Boston
Lincolnshire
PE20 2PU





REGISTERED NUMBER: 08398099 (England and Wales)





ACCOUNTANTS: Duncan & Toplis Limited
5 Resolution Close
Endeavour Park
Boston
Lincolnshire
PE21 7TT

GOLDEN GROVE NURSERY LIMITED (REGISTERED NUMBER: 08398099)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 750,878 785,825

CURRENT ASSETS
Stocks 110,256 64,709
Debtors 5 293,269 231,659
Cash at bank and in hand 455,027 392,953
858,552 689,321
CREDITORS
Amounts falling due within one year 6 176,011 86,293
NET CURRENT ASSETS 682,541 603,028
TOTAL ASSETS LESS CURRENT LIABILITIES 1,433,419 1,388,853

CREDITORS
Amounts falling due after more than one year 7 (690,078 ) (700,233 )

PROVISIONS FOR LIABILITIES (76,025 ) (82,471 )
NET ASSETS 667,316 606,149

CAPITAL AND RESERVES
Called up share capital 8 10,000 10,000
Capital redemption reserve 277,900 267,900
Retained earnings 379,416 328,249
SHAREHOLDERS' FUNDS 667,316 606,149

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 August 2025 and were signed on its behalf by:





E R Ward - Director


GOLDEN GROVE NURSERY LIMITED (REGISTERED NUMBER: 08398099)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Golden Grove Nursery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax. Sales are recognised upon despatch.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 5% on cost and not provided
Plant and machinery etc - 25% on reducing balance, 15% on reducing balance, 10% on cost and 5% on cost

Tangible assets are valued at cost less accumulated depreciation.

Stocks
Stocks and work in progress are stated at the lower of cost and estimated selling price, less further costs expected to be incurred to completion and disposal. Provision is made for obsolete and slow moving stock.

Financial instruments
The company has chosen to adopt the FRS102 1A in respect of financial instruments.

Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at transaction price, unless the arrangement constitute a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in the income statement.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


GOLDEN GROVE NURSERY LIMITED (REGISTERED NUMBER: 08398099)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Government grants
Government grants that are classified as revenue grants are recognised in the income statement in the period to which they relate, with any amounts not yet recognised being shown as a liability in the statement of financial position.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 22 (2024 - 23 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2024 554,048 1,024,272 1,578,320
Additions - 63,991 63,991
Disposals - (24,203 ) (24,203 )
At 31 March 2025 554,048 1,064,060 1,618,108
DEPRECIATION
At 1 April 2024 116,830 675,665 792,495
Charge for year 10,621 80,821 91,442
Eliminated on disposal - (16,707 ) (16,707 )
Reclassification/transfer (2,822 ) 2,822 -
At 31 March 2025 124,629 742,601 867,230
NET BOOK VALUE
At 31 March 2025 429,419 321,459 750,878
At 31 March 2024 437,218 348,607 785,825

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 273,226 213,485
Other debtors 20,043 18,174
293,269 231,659

GOLDEN GROVE NURSERY LIMITED (REGISTERED NUMBER: 08398099)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 41,933 51,768
Taxation and social security 105,111 14,342
Other creditors 28,967 20,183
176,011 86,293

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Other creditors 690,078 700,233

Amounts falling due in more than five years:

Repayable otherwise than by instalments
Redeemable preference shares 689,614 699,614

No dividends are payable on the redeemable preference shares.

The company and each holder of redeemable preference shares have the right to redeem all or any of the redeemable preference shares upon giving notice to the company. The amount redeemable by the company or any or all of the holders of redeemable preference shares in any financial year shall be limited to an aggregate of £100,000 or such larger amount as may be agreed by the company.

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
5,000 Ordinary A £1 5,000 5,000
4,000 Ordinary B £1 4,000 4,000
1,000 Ordinary C £1 1,000 1,000
10,000 10,000

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year loans were made to the directors with the balance owed to the company at the year end date being £0 (2024 : £1,600). The loans made to the directors are unsecured, interest free and repayable on demand.